Cargando…
Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation
Chronic liver injury causing liver fibrosis is a major cause of morbidity and mortality worldwide. Targeting the suppression of hepatic stellate cell (HSC) activation is recognized as an effective strategy for the treatment of liver fibrosis. Ellagic acid (EA), a natural polyphenol product isolated...
Autores principales: | Li, Lihua, Wang, Kunpeng, Jia, Rongjun, xie, Jing, Ma, Liman, Hao, Zhiqing, Zhang, Weiwei, Mo, Jinggang, Ren, Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425030/ https://www.ncbi.nlm.nih.gov/pubmed/36029649 http://dx.doi.org/10.1016/j.redox.2022.102435 |
Ejemplares similares
-
Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease
por: Bao, Wen-Dai, et al.
Publicado: (2021) -
Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin
por: Tang, Zheng, et al.
Publicado: (2021) -
Human macrophage ferroportin biology and the basis for the ferroportin disease
por: Sabelli, Manuela, et al.
Publicado: (2017) -
Pediatric Ferroportin Disease
por: Galicia-Poblet, Gonzalo, et al.
Publicado: (2016) -
New Biosourced Flame Retardant Agents Based on Gallic and Ellagic Acids for Epoxy Resins
por: Karaseva, Valeriia, et al.
Publicado: (2019)